Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Acquired byAbbott Labs
Price$310M
Date7/2013
TermsCash

General Information

Offices

Webster, USA
253 Medical Center Blvd.
Webster, TX, 77598
USA

People

President and CEO
Boards of Directors
Director

Funding

TOTAL $58.9M
FUNDING TOTAL $58.9M
Partial Close, 5/2010
$12.9M
Series D, 10/2010
Piper Jaffray Private Capital Group
PTV Sciences
Bay City Capital
RiverVest
Heron Capital
$46M
DEBT TOTAL $831k
Debt, 3/2012
$831k

Tags

IDEV Technologies

IDEV Technologies is an emerging growth medical device company focused on the development of products for endovascular and interventional applications. Currently, IDEV markets SUPERA, a novel self-expanding nitinol stent. Using a patented interwoven design, SUPERA offers improved flexibility, radial strength, and kink and crush resistance compared to other marketed stents. SUPERA is currently approved for use in the treatment of biliary strictures in the US. IDEV is currently enrolling patients in the SUPERB IDE trial to study SUPERA’s safety and efficacy when used in the superficial femoral artery (SFA).

Recent Milestones

Videos

Screenshots

Sources

  1. Abbott to Acquire IDEV Technologies to Expand Global Peripheral Technology Portfolio (abbott.com) [edit]
  2. SEC (sec.gov) [edit]
  3. IDEV Technologies Completes $46M Series D Financing (finsmes.com) [edit]
  4. SEC (sec.gov) [edit]
Edit This Page
Last Edited 3/7/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy